Dow Down0.78% Nasdaq Down1.13%

Skystar Bio Pharmaceutical Company (SKBI)

-NasdaqCM
0.19 0.00(0.00%) May 2, 3:40PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 42,484   33,587   52,788  
Cost of Revenue20,993  15,095  26,563  
Gross Profit 21,491   18,492   26,226  
Operating Expenses
Research Development956  2,154  2,814  
Selling General and Administrative7,522  7,787  8,161  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 13,013   8,551   15,250  
Income from Continuing Operations
Total Other Income/Expenses Net531  594  1,420  
Earnings Before Interest And Taxes13,544  9,145  16,670  
Interest Expense612  765  141  
Income Before Tax12,932  8,381  16,529  
Income Tax Expense2,401  2,168  2,871  
Minority Interest -   -   -  
Net Income From Continuing Ops10,530  6,212  13,658  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 10,530   6,212   13,658  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 10,530   6,212   13,658  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.